Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.50% is 56% below its 5-year average of 1.14%, near the low end of its 5-year range (0.50%–1.68%).
As of the fiscal period ended Tuesday, June 30, 2026. 59.18% below its 12-month average of 1.22%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.50%.
DEBT TO ASSETS RATIO
0.50%
DEBT TO ASSETS RATIO AVG TTM
1.22%
DEBT TO ASSETS RATIO AVG 3Y
0.96%
DEBT TO ASSETS RATIO AVG 5Y
1.14%
DEBT TO ASSETS RATIO AVG 10Y
0.84%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-59.18%
CURRENT VS 3Y AVG
-48.13%
CURRENT VS 5Y AVG
-56.34%
CURRENT VS 10Y AVG
-40.59%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 664 covered companies
CURRENT VS SECTOR MEDIAN
+399.19%
vs the sector median at left
InflaRx N.V.
Market Cap
$241.56M
Debt to Assets Ratio
0.50%
TTM Avg
1.22%
3Y Avg
0.96%
5Y Avg
1.14%
Market Cap
$241.60M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$242.56M
Debt to Assets Ratio
0.15%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$243.01M
Debt to Assets Ratio
9.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$244.00M
Debt to Assets Ratio
0.68%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$247.43M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InflaRx N.V. (IFRX) | $241.56M | 0.50% | 1.22% | 0.96% | 1.14% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $241.60M | 0.03% | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $242.56M | 0.15% | N/A | N/A | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $243.01M | 9.29% | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $244.00M | 0.68% | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $237.69M | 0.33% | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $246.64M | 0.04% | N/A | N/A | N/A |
| BioAge Labs Inc. (BIOA)vs › | $236.06M | 0.01% | N/A | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $247.43M | 0.00% | N/A | N/A | N/A |
| MacroGenics, Inc. (MGNX)vs › | $234.83M | 0.10% | N/A | N/A | N/A |
Debt/Assets
0.5%
Debt/Equity
0.01
Current Ratio
8.22
Interest Coverage
-1280.4x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.50% |
| 2026-03-31 | 1.68% |
| 2025-12-31 | 1.63% |
| 2025-09-30 | 1.49% |
| 2025-06-30 | 0.82% |
| 2025-03-31 | 0.81% |
| 2024-12-31 | 1.06% |
| 2024-09-30 | 1.13% |
| 2024-06-30 | 1.07% |
| 2024-03-31 | 1.03% |
| 2023-12-31 | 0.93% |
| 2023-09-30 | 0.87% |
| 2023-06-30 | 0.88% |
| 2023-03-31 | 1.46% |
| 2022-12-31 | 1.32% |
| 2022-09-30 | 1.31% |
| 2022-06-30 | 1.34% |
| 2022-03-31 | 1.17% |
| 2021-12-31 | 1.14% |
| 2021-09-30 | 1.17% |
| 2021-06-30 | 1.19% |
| 2021-03-31 | 0.32% |
| 2020-12-31 | 0.63% |
| 2020-09-30 | 0.63% |
| 2020-06-30 | 0.70% |
| 2020-03-31 | 0.67% |
| 2019-12-31 | 0.70% |
| 2019-09-30 | 0.64% |
| 2019-06-30 | 0.68% |
| 2019-03-31 | 0.44% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 239.07% |
| 2017-06-30 | 213.01% |
| 2016-12-31 | 181.04% |
